Secreted phospholipase A2-IIA modulates key regulators of proliferation on astrocytoma cells

Journal of Neurochemistry

Volumn 111, Issue 4, 2009, Pages 988-999

  Martín, Rubén ^a   Hernández, Marita ^a   Ibeas, Elvira ^a   Fuentes, Lucia ^a   Salicio, Veronica ^a   Arnés, Mercedes ^a   Nieto, María Luisa ^a  

^a Universidad de Valladolid y Consejo Superior de Investigaciones Científicas   (Spain)

Author keywords

Akt; Astrocytoma cells; Human group IIA secreted phospholipase A2; P70 S6 kinase; Proliferation; Reactive oxygen species

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ACETYLCYSTEINE; ALLOPURINOL; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 GROUP II; PHOSPHOLIPASE A2 GROUP IIA; PROTEIN KINASE B; PROTEIN P70; PROTEIN S6; RAF PROTEIN; RAPAMYCIN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; ROTENONE; S6 KINASE; UNCLASSIFIED DRUG; ENZYME INHIBITOR; ONCOPROTEIN;

ARTICLE; ASTROCYTOMA; ASTROCYTOMA CELL; BRAIN CANCER; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; DRUG EFFECT; EXTRACELLULAR FLUID; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOLOGY; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE;

ASTROCYTOMA; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME INHIBITORS; EXTRACELLULAR FLUID; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GROUP II PHOSPHOLIPASES A2; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; ONCOGENE PROTEIN V-AKT; PROTO-ONCOGENE PROTEINS C-RAF; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 70350130979     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06377.x     Document Type: Article

References (47)

1. 2 is increased in peritoneal and pleural effusions in patients with various types of cancer. Int. J. Cancer 74, 245 250.
2. Adibhatla R. T. Hatcher J. F. (2007) Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat. Brain Res. 1134, 199 205.
3. 2 in colon tumor cells potentiates tumor growth. Mol. Carcinog. 46, 106 116.
4. 2. Blood 102, 2901 2909.
5. Cantley L. C. (2002) The phosphoinositide 3-kinase pathway. Science 296, 1655 1657.
6. Chen Q., Olashaw N. Wu J. (1995) Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogenactivated protien kinase kinase activation pathway. J. Biol. Chem. 270, 28499 28502.
7. Choi Y.-A., Lim H.-K., Kim J.-R., Lee C.-H., Kim Y.-J., Kang S.-S. Baek S.-H. (2004) Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway. J. Biol. Chem. 279, 36579 36585.
8. Dharmappa K. K., Kumar R. V., Nataraju A., Mohamed R., Shivaprasad H. V. Vishwanath B. S. (2009) Anti-inflammatory activity of oleanolic acid by inhibition of secretory phospholipase A2. Planta Med. 75, 211 215.
9. 2 in prostate cancer. Cancer Lett. 240, 9 16.
10. Fingar D. C., Richardson C. J., Tee A. R., Cheatham L., Tsou C. Blenis J. (2004) mTOR Controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell. Biol. 24, 200 216.
11. Fonteh A. N., Marion C. R., Barham B. J. et al. (2001) Enhancement of mast cell survival: a novel function of some secretory phospholipase A(2) isotypes. J. Immunol. 167, 4161 4171.
12. 2. Toxicon 44, 473 481.
13. Gao N., Flynn D. C., Zhang Z. et al. (2004) G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am. J. Physiol. Cell Physiol. 287, C281 C291.
14. Granata F., Frattini A., Loffredo S., Del Prete A., Sozzani S., Marone G. Triggiani M. (2006) Signaling events involved in cytokine and chemokine production induced by secretory phospholipase A2 in human lung macrophages. Eur. J. Immunol. 36, 1938 1950.
15. 2 in the human astrocytoma cell line 1321N1. J. Biol. Chem. 273, 606 612.
16. Hernández M., Barrero M. J., Alvarez J., Montero M., Sánchez Crespo M. Nieto M. L. (1999) Secretory phospholipase A2 induces phospholipase Cgamma-1 activation and Ca2+ mobilization in the human astrocytoma cell line 1321N1 by a mechanism independent of its catalytic activity. Biochem. Biophys. Res. Commun. 260, 99 104.
17. Iijima Y., Laser M., Shiraishi H. et al. (2002) c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells. J. Biol. Chem. 277, 23065 23075.
18. Isabelle M., Vergeade A., Moritz F. et al. (2007) NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. Mol. Cell. Cardiol. 42, 326 332.
19. Ishizuka Y., Kakiya N., Nawa H. Takei N. (2008) Leucine induces phosphorylation and activation of p70S6K in cortical neurons via the system L amino acid transporter. J. Neurochem. 106, 934 942.
20. Jensen S. S., Andresen T. L., Davidsen J., Høyrup P., Shnyder S. D., Bibby M. C., Gill J. H. Jørgensen K. (2004) Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids. Mol. Cancer Ther. 3, 1451 1458.
21. 2. J. Biol. Chem. 264, 5768 5775.
22. Krizaj I. Gubensek F. (2000) Neuronal receptors for phospholipases A(2) and beta-neurotoxicity. Biochimie 82, 807 814.
23. 2. Trends Pharmacol. Sci. 20, 162 170.
24. LaMorte V. J., Kennedy E. D., Collins L. R., Goldstein D., Harootunian A. T., Brown J. H. Feramisco J. R. (1993) A requirement for Ras protein function in thrombin-stimulated mitogenesis in astrocytoma cells. J. Biol. Chem. 268, 19411 19415.
25. Lehman N., Ledford B., Di Fulvio M., Frondorf K., McPhail L. C. Gomez-Cambronero J. (2007) Phospholipase D2-derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR. FASEB J. 21, 1075 1087.
26. Leung S. Y., Chen X., Chu K. M. et al. (2002) Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc. Natl Acad. Sci. USA 99, 16203 16208.
27. Li N., Ragheb K., Lawler G., Sturgis J, Rajwa B., Melendez J. A. Robinson J. P. (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 278, 8516 8525.
28. Martín R., Carvalho J., Ibeas E., Hernández M., Ruiz-Gutierrez V. Nieto M. L. (2007) Acidic triterpenes compromise growth and survival of astrocytoma cell lines by regulating reactive oxygen species accumulation. Cancer Res. 67, 3741 3751.
29. 2-IIA and ROS generation in peripheral mitochondria are critical for neuronal death. Brain Res. 1153, 43 51.
30. Menschikowski M., Hagelgans A. Siegert G. (2006) Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? Prostaglandins Other Lipid Mediat. 79, 1 33.
31. Menschikowski M., Hagelgans A., Gussakovsky E., Kostka H., Paley E. L. Siegert G. (2008) Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms. Neoplasia 10, 279 286.
32. Mijatovic S., Maksimovic-Ivanic D., Radovic J., Miljkovic Dj., Harhaji Lj., Vuckovic O., Stosic-Grujicic S., Mostarica Stojkovic M. Trajkovic V. (2005) Anti-glioma action of aloe emodin: the role of ERK inhibition. Cell. Mol. Life Sci. 62, 589 598.
33. Paget S. (1889) The distribution of secondary growth in cancer of the breast. Lancet 1, 571 573.
34. Park D. W., Kim J. R., Kim S. Y., Sonn J. K., Bang O. S., Kang S. S., Kim J. H. Baek S. H. (2003) Akt as a mediator of secretory phospholipase A2 receptor-involved inducible nitric oxide synthase expression. J. Immunol. 170, 2093 2099.
35. Putz T., Ramoner R., Gander H., Rahm A., Bartsch G., Bernardo K., Ramsay S. Thurnher M. (2007) Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cells. Cancer Immunol. Immunother. 56, 627 640.
36. Riemenschneider M. J., Betensky R. A., Pasedag S. M. Louis D. N. (2006) Akt activation in human glioblastomas enhances proliferation via TSC2 and S6 k9inase signaling. Cancer Res. 66, 5618 5623.
37. Saegusa J., Akakura N., Wu C. Y., Hoogland C., Ma Z., Lam K. S., Liu F. T., Takada Y. K. Takada Y. (2008) Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner. J. Biol. Chem. 283, 26107 26115.
38. Serù R., Mondola P., Damiano S., Svegliati S., Agnese S., Avvedimento E. V. Santillo M. (2004) HaRas activates the NADPH oxidase complex in human neuroblastoma cells via extracellular signal-regulated kinase 1/2 pathway. J. Neurochem. 91, 613 622.
39. Shahbazian D., Roux P. P., Mieulet V. et al. (2006) The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 25, 2781 2791.
40. Silliman C. C., Moore E. E., Zallen G. et al. (2002) Presence of the M-type sPLA2 receptor on neutrophils and its role in elastase release and adhesion. Am. J. Physiol. Cell Physiol. 283, C1102 C1113.
41. Sonoda Y., Ozawa T., Aldape K. D., Deen D. F., Berger M. S. Pieper R. O. (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res. 61, 6674 6678.
42. Sun G. Y., Xu J., Jensen M. D. Simonyi A. (2004) Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 45, 205 213.
43. Triggiani M., Granata F., Oriente A., Gentile M., Petraroli A., Balestrieri B. Marone G. (2002) Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes. Eur. J. Immunol. 32, 67 76.
44. Triggiani M., Granata F., Balestrieri B., Petraroli A., Scalia G., Del Vecchio L. Marone G. (2003) Secretory phospholipases A2 activate selective functions in human eosinophils. J. Immunol. 170, 3279 3288.
45. Wang X., McCullough K. D., Franke T. F. Holbrook N. J. (2000) Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 275, 14624 14631.
46. Webb N. R. (2005) Secretory phospholipase enzymes in atherogenesis. Curr. Opin. Lipidol. 16, 341 344.
47. 2 induces neuronal cell death via apoptosis. Mol. Pharmacol. 61, 114 126. (Pubitemid 34049518)